Hospital news

Monday, June 5, 2023 Drug prolongs time before brain tumour grows back As part of the Phase 3 clinical trial, research participants with low-grade gliomas, taking the drug vorasidenib remained free from tumour re-growth for 27.7 months, as of the time of study read-out.
Read full story

Wednesday, May 24, 2023 Sunnybrook scientists awarded CIHR funding to research mpox and other zoonotic diseases CIHR’s Centre for Research on Pandemic Preparedness and Health Emergencies is providing funding for eleven of the mpox projects, while the HIV/AIDS and Sexually Transmitted and Blood Borne Infections (STBBI) Research Initiative is funding two projects.
Read full story

Thursday, May 18, 2023 Sunnybrook's Tory Trauma Program first outside U.S. to be verified as a level 1 trauma centre by the American College of Surgeons Sunnybrook is the first hospital outside of the U.S. to achieve this standard
Read full story